Two Japanese Textile Firms Expand Pharmaceutical Businesses
This article was originally published in PharmAsia News
Executive SummaryTwo Japanese textile companies are expanding their pharmaceutical holdings as one way to guard against bad economic times. Asahi Kasei plans to expand one of its facilities specializing in drug compounds at a cost of about $10.4 million. Toray Industries says it will double the capacity of one of its plants to produce tablets and capsules as early as autumn, including Toray's anti-itch drug for dialysis patients, currently outsourced. (Click here for more - a subscription may be required
You may also be interested in...
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
As its CEO Jerome Carle steps down following a 67% slump in sales to date this year, UAE-based Julphar is hopeful of putting manufacturing problems behind it under a new management team.